Foresite Capital Management V

Latest statistics and disclosures from Foresite Capital Management V's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management V

Foresite Capital Management V holds 7 positions in its portfolio as reported in the September 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Hims & Hers Health Com Cl A (HIMS) 37.5 $24M 3.7M 6.29
 View chart
Disc Medicine (IRON) 18.3 $11M 244k 46.98
 View chart
Theseus Pharmaceuticals 17.6 $11M +14% 4.1M 2.69
 View chart
Aclaris Therapeutics (ACRS) 13.8 $8.6M 1.3M 6.85
 View chart
Kinnate Biopharma (KNTE) 7.9 $4.9M 3.5M 1.40
 View chart
Compass Therapeutics (CMPX) 3.9 $2.5M -5% 1.2M 1.97
 View chart
Pharvaris N V (PHVS) 1.1 $692k -2% 33k 20.87
 View chart

Past Filings by Foresite Capital Management V

SEC 13F filings are viewable for Foresite Capital Management V going back to 2020